+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
N-Formyl Peptide Receptor 2 Market - Global Forecast 2026-2032- Product Image
N-Formyl Peptide Receptor 2 Market - Global Forecast 2026-2032- Product Image
Sale

N-Formyl Peptide Receptor 2 Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6277794
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

N-Formyl Peptide Receptor 2: Executive Overview

N-formyl peptide receptor 2 (FPR2), also known as ALX/FPR2, is a G-protein-coupled receptor involved in innate immune signaling, inflammation resolution, host defense, and tissue repair. Its activity is linked to diverse endogenous and microbial ligands, making it relevant to research on inflammatory, infectious, cardiovascular, respiratory, and neurological disorders. The field remains scientifically complex because FPR2 signaling can vary by ligand, cellular context, receptor trafficking, and downstream pathway.

From Inflammatory Activation to Resolution Biology

Research is increasingly distinguishing between pathways that amplify inflammation and those that promote its resolution. FPR2 is central to this shift because it can respond to both pro-inflammatory and pro-resolving signals. Advances in receptor pharmacology, biased signaling, structural biology, lipid mediator analysis, and single-cell profiling are helping researchers define how FPR2 influences neutrophil migration, macrophage behavior, epithelial responses, vascular function, and repair processes. Translational progress depends on improving ligand selectivity and confirming target engagement in relevant tissues.

Artificial Intelligence Accelerates FPR2 Discovery and Interpretation

Artificial intelligence can support FPR2 research by integrating sequence, structure, ligand-screening, transcriptomic, proteomic, and clinical datasets. Machine-learning models may help prioritize compounds, predict receptor-ligand interactions, classify signaling profiles, and identify disease contexts in which FPR2 modulation is most biologically plausible. However, computational results require experimental validation because receptor conformational flexibility, ligand bias, species differences, and assay conditions can produce divergent outcomes. Responsible use therefore combines model transparency, curated datasets, orthogonal assays, and reproducible validation.

Regional Research Priorities Span Immunology, Drug Discovery, and Translational Medicine

North America combines strong immunology, pharmacology, and translational research capacity, with emphasis on mechanism-driven therapeutics and advanced biomarker development. Europe, including the European Union, has substantial activity in inflammation resolution, systems biology, and collaborative biomedical research. Asia-Pacific is supported by expanding biotechnology, pharmaceutical, and academic capabilities, with Japan, China, South Korea, India, and Australia contributing across receptor biology and drug discovery. Latin America, including Brazil and Mexico, is positioned to strengthen work on infectious disease, inflammatory conditions, and locally relevant translational questions. Research ecosystems in the Middle East and Africa are developing through investments in biomedical infrastructure, clinical networks, and partnerships, although access to specialized platforms remains uneven.

Multilateral Groups Shape Collaboration, Regulation, and Research Capacity

ASEAN countries can benefit from coordinated studies of infectious and inflammatory diseases, shared biobanking standards, and regional translational networks. BRICS collaboration can support complementary capabilities in molecular biology, preclinical testing, data science, and clinical research. The European Union provides a framework for cross-border research, regulatory alignment, and data-sharing initiatives, while the G7 brings together mature biomedical ecosystems with strong capacity in advanced analytics and translational science. GCC members can expand regional expertise through shared research infrastructure and partnerships. NATO countries may contribute through broader preparedness-related research on host defense, inflammation, and biomedical resilience, while maintaining clear separation between health research and defense applications.

Country-Level Capabilities Reveal Complementary FPR2 Opportunities

The United States and Canada contribute deeply established biomedical research and translational networks. The United Kingdom, France, Germany, Italy, and Spain offer strong capabilities in immunology, pharmacology, clinical science, and collaborative European research. China, Japan, South Korea, India, and Australia combine growing or established strengths in molecular research, biotechnology, and data-intensive discovery. Brazil and Mexico provide important perspectives on infectious disease and inflammation in diverse populations. Russia retains relevant scientific expertise but may face constraints related to international collaboration and access to some research resources. Across these countries, progress will depend on validated assays, representative biological models, and stronger links between academic findings and clinical development.

Prioritize Selective Biology, Translational Evidence, and Reproducible Partnerships

Industry leaders should first define the intended FPR2 mechanism-pro-inflammatory blockade, pro-resolving activation, or context-dependent modulation-before selecting screening and development strategies. Programs should use ligand-bias profiling, receptor occupancy or engagement measurements, human-relevant cellular systems, and species-aware preclinical design. Combining AI-based prioritization with orthogonal experimental confirmation can improve efficiency without replacing laboratory evidence. Partnerships with academic groups, clinical investigators, and regional research centers can broaden biological insight and patient relevance. Development teams should also establish biomarkers early, monitor safety implications of immune modulation, and use transparent data standards to support reproducibility.

Methodology: Evidence Synthesis Across Biology, Regions, and Translation

This executive summary uses a structured review of established scientific knowledge concerning FPR2 biology, ligand-dependent signaling, inflammation resolution, receptor pharmacology, translational research, and enabling technologies. Insights were organized across the required regions, country groupings, and individual countries by considering documented research capabilities, biomedical infrastructure, collaboration patterns, and disease-relevant expertise. Artificial intelligence considerations were framed as applications supported by current computational and experimental research practices. No market estimates, market shares, forecasts, or company-specific claims were used.

FPR2 Progress Depends on Connecting Mechanism to Clinical Relevance

FPR2 remains an important research target because it sits at the intersection of innate immunity, inflammation, resolution, and tissue repair. The most credible path forward is not broad receptor modulation alone, but precise control of ligand-specific and cell-specific signaling supported by rigorous biomarkers and human-relevant models. Regional and international collaboration can accelerate validation, while artificial intelligence can improve prioritization and biological interpretation when paired with transparent experimental testing. Leaders that align mechanistic clarity, translational discipline, and reproducible partnerships will be best positioned to convert FPR2 biology into meaningful therapeutic insight.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. N-Formyl Peptide Receptor 2 Market, by Therapeutic Area
7.1. Introduction
7.2. Cardiovascular
7.2.1. Atherosclerosis And Vascular Inflammation
7.2.2. Heart Failure
7.2.3. Myocardial Infarction
7.3. Inflammation
7.3.1. Inflammatory Bowel Disease
7.3.2. Osteoarthritis
7.3.3. Psoriasis And Dermatologic Inflammation
7.3.4. Rheumatoid Arthritis
7.4. Neurology
7.4.1. Alzheimer's Disease And Neuroinflammation
7.4.2. Multiple Sclerosis
7.4.3. Parkinson's Disease
7.5. Oncology
7.5.1. Metastasis And Cancer Progression
7.5.2. Tumor Microenvironment Modulation
7.6. Respiratory
7.6.1. Acute Respiratory Distress Syndrome
7.6.2. Asthma
7.6.3. Chronic Obstructive Pulmonary Disease
7.7. Sepsis And Infectious Disease
7.7.1. Acute Infectious Inflammation
7.7.2. Sepsis
8. N-Formyl Peptide Receptor 2 Market, by Molecule Type
8.1. Introduction
8.2. Biologics
8.2.1. Fusion Proteins And Biologics
8.2.2. Monoclonal Antibodies
8.3. Peptides
8.3.1. Peptidomimetics
8.3.2. Synthetic Peptides
8.4. Small Molecules
8.4.1. Injectable Small Molecules
8.4.2. Oral Small Molecules
9. N-Formyl Peptide Receptor 2 Market, by Product Type
9.1. Introduction
9.2. Agonists
9.2.1. Biased Agonists
9.2.2. Full Agonists
9.2.3. Partial Agonists
9.3. Allosteric Modulators
9.3.1. Negative Allosteric Modulators
9.3.2. Positive Allosteric Modulators
9.4. Antagonists
9.4.1. Competitive Antagonists
9.4.2. Noncompetitive Antagonists
10. N-Formyl Peptide Receptor 2 Market, by Route Of Administration
10.1. Introduction
10.2. Inhalation
10.2.1. Dry Powder Inhalers
10.2.2. Nebulized Formulations
10.3. Injectable
10.3.1. Intramuscular
10.3.2. Intravenous
10.3.3. Subcutaneous
10.4. Oral
10.4.1. Oral Solutions And Suspensions
10.4.2. Tablets And Capsules
10.5. Topical
10.5.1. Topical Creams And Gels
10.5.2. Transdermal Patches
11. N-Formyl Peptide Receptor 2 Market, by End User
11.1. Introduction
11.2. CROs And Research Institutions
11.2.1. Academic And Research Institutes
11.2.2. Contract Research Organizations
11.3. Healthcare Providers And Labs
11.3.1. Hospitals And Clinics
11.3.2. Specialty And Reference Laboratories
11.4. Pharmaceutical And Biotechnology Companies
11.4.1. Big Pharmaceutical Companies
11.4.2. Specialty Biotech
12. N-Formyl Peptide Receptor 2 Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. N-Formyl Peptide Receptor 2 Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. N-Formyl Peptide Receptor 2 Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abcam plc
16.2. Alomone Labs Ltd
16.3. Amgen Inc
16.4. AstraZeneca plc
16.5. Bachem Holding AG
16.6. Bio-Techne Corporation
16.7. BioGems International Inc
16.8. Bristol-Myers Squibb Company
16.9. DiscoverX Corporation
16.10. Eli Lilly and Company
16.11. Enzo Life Sciences Inc
16.12. GenScript Biotech Corporation
16.13. Grünenthal GmbH
16.14. Ipsen Pharma SAS
16.15. Kyorin Pharmaceutical Co Ltd
16.16. MedChemExpress LLC
16.17. Merck KGaA
16.18. Novacell Technology Inc
16.19. Novartis AG
16.20. Novonesis A/S
16.21. PolyPeptide Group AG
16.22. Sanofi S.A.
16.23. Thermo Fisher Scientific Inc
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global N-Formyl Peptide Receptor 2 Market, Years Considered for the Study
FIGURE 2. Global N-Formyl Peptide Receptor 2 Market, Research Design
FIGURE 3. Global N-Formyl Peptide Receptor 2 Market, Research Framework
FIGURE 4. Global N-Formyl Peptide Receptor 2 Market, Data Triangulation
FIGURE 5. Global N-Formyl Peptide Receptor 2 Market Size, 2017-2032 (USD Million)
FIGURE 6. Global N-Formyl Peptide Receptor 2 Market Size, by Therapeutic Area, 2025 vs 2032 (%)
FIGURE 7. Global N-Formyl Peptide Receptor 2 Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global N-Formyl Peptide Receptor 2 Market Size, by Molecule Type, 2025 vs 2032 (%)
FIGURE 9. Global N-Formyl Peptide Receptor 2 Market Size, by Molecule Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global N-Formyl Peptide Receptor 2 Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 11. Global N-Formyl Peptide Receptor 2 Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global N-Formyl Peptide Receptor 2 Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 13. Global N-Formyl Peptide Receptor 2 Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global N-Formyl Peptide Receptor 2 Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global N-Formyl Peptide Receptor 2 Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global N-Formyl Peptide Receptor 2 Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global N-Formyl Peptide Receptor 2 Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global N-Formyl Peptide Receptor 2 Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global N-Formyl Peptide Receptor 2 Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global N-Formyl Peptide Receptor 2 Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global N-Formyl Peptide Receptor 2 Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global N-Formyl Peptide Receptor 2 Market Segmentation & Coverage
TABLE 2. Global N-Formyl Peptide Receptor 2 Market Size, 2017-2032 (USD Million)
TABLE 3. Global N-Formyl Peptide Receptor 2 Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 4. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Atherosclerosis And Vascular Inflammation Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Atherosclerosis And Vascular Inflammation Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Atherosclerosis And Vascular Inflammation Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Heart Failure Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Heart Failure Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Heart Failure Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Myocardial Infarction Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Myocardial Infarction Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Myocardial Infarction Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Inflammation Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Inflammation Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Inflammation Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Inflammatory Bowel Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Inflammatory Bowel Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Inflammatory Bowel Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Osteoarthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Osteoarthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Osteoarthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Psoriasis And Dermatologic Inflammation Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Psoriasis And Dermatologic Inflammation Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Psoriasis And Dermatologic Inflammation Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Rheumatoid Arthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Rheumatoid Arthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Rheumatoid Arthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Alzheimer's Disease And Neuroinflammation Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Alzheimer's Disease And Neuroinflammation Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Alzheimer's Disease And Neuroinflammation Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Multiple Sclerosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Multiple Sclerosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Multiple Sclerosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Parkinson's Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Parkinson's Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Parkinson's Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Metastasis And Cancer Progression Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Metastasis And Cancer Progression Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Metastasis And Cancer Progression Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Tumor Microenvironment Modulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Tumor Microenvironment Modulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Tumor Microenvironment Modulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Respiratory Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Respiratory Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Respiratory Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Acute Respiratory Distress Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Acute Respiratory Distress Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Acute Respiratory Distress Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Asthma Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Asthma Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Asthma Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Chronic Obstructive Pulmonary Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Chronic Obstructive Pulmonary Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Chronic Obstructive Pulmonary Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Sepsis And Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Sepsis And Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Sepsis And Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Acute Infectious Inflammation Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Acute Infectious Inflammation Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Acute Infectious Inflammation Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Sepsis Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Sepsis Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Sepsis Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global N-Formyl Peptide Receptor 2 Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 74. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Fusion Proteins And Biologics Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Fusion Proteins And Biologics Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Fusion Proteins And Biologics Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Peptidomimetics Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Peptidomimetics Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Peptidomimetics Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Synthetic Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Synthetic Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Synthetic Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Small Molecules Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Small Molecules Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Small Molecules Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Injectable Small Molecules Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Injectable Small Molecules Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Injectable Small Molecules Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Oral Small Molecules Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Oral Small Molecules Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Oral Small Molecules Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global N-Formyl Peptide Receptor 2 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. Global Agonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Agonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Agonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Biased Agonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Biased Agonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Biased Agonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Full Agonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Full Agonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Full Agonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Partial Agonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Partial Agonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Partial Agonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Allosteric Modulators Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Allosteric Modulators Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Allosteric Modulators Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Negative Allosteric Modulators Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Negative Allosteric Modulators Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Negative Allosteric Modulators Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Positive Allosteric Modulators Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Positive Allosteric Modulators Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Positive Allosteric Modulators Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Antagonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Antagonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Antagonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Competitive Antagonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Competitive Antagonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Competitive Antagonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Noncompetitive Antagonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Noncompetitive Antagonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Noncompetitive Antagonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global N-Formyl Peptide Receptor 2 Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 133. Global Inhalation Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Inhalation Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Inhalation Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Dry Powder Inhalers Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Dry Powder Inhalers Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Dry Powder Inhalers Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Nebulized Formulations Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Nebulized Formulations Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Nebulized Formulations Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Oral Solutions And Suspensions Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Oral Solutions And Suspensions Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Oral Solutions And Suspensions Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Tablets And Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Global Tablets And Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. Global Tablets And Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 163. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. Global Topical Creams And Gels Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. Global Topical Creams And Gels Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. Global Topical Creams And Gels Market Size, by Country, 2017-2032 (USD Million)
TABLE 169. Global Transdermal Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 170. Global Transdermal Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. Global Transdermal Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 172. Global N-Formyl Peptide Receptor 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Global CROs And Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global CROs And Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global CROs And Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 182. Global Healthcare Providers And Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. Global Healthcare Providers And Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. Global Healthcare Providers And Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 185. Global Hospitals And Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. Global Hospitals And Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. Global Hospitals And Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 188. Global Specialty And Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 189. Global Specialty And Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. Global Specialty And Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 191. Global Pharmaceutical And Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 192. Global Pharmaceutical And Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 193. Global Pharmaceutical And Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 194. Global Big Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 195. Global Big Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. Global Big Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 197. Global Specialty Biotech Market Size, by Region, 2017-2032 (USD Million)
TABLE 198. Global Specialty Biotech Market Size, by Group, 2017-2032 (USD Million)
TABLE 199. Global Specialty Biotech Market Size, by Country, 2017-2032 (USD Million)
TABLE 200. Global N-Formyl Peptide Receptor 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 201. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 202. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 203. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 204. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 205. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 206. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 207. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 208. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Sepsis And Infectious Disease, 2017-2032 (USD Million)
TABLE 209. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 210. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 211. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 212. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Small Molecules, 2017-2032 (USD Million)
TABLE 213. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Agonists, 2017-2032 (USD Million)
TABLE 215. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Allosteric Modulators, 2017-2032 (USD Million)
TABLE 216. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Antagonists, 2017-2032 (USD Million)
TABLE 217. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 218. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 219. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 220. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Oral, 2017-2032 (USD Million)
TABLE 221. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Topical, 2017-2032 (USD Million)
TABLE 222. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by CROs And Research Institutions, 2017-2032 (USD Million)
TABLE 224. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Healthcare Providers And Labs, 2017-2032 (USD Million)
TABLE 225. Asia-Pacific N-Formyl Peptide Receptor 2 Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 226. North America N-Formyl Peptide Receptor 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 227. North America N-Formyl Peptide Receptor 2 Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 228. North America N-Formyl Peptide Receptor 2 Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 229. North America N-Formyl Peptide Receptor 2 Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 230. North America N-Formyl Peptide Receptor 2 Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 231. North America N-Formyl Peptide Receptor 2 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 232. North America N-Formyl Peptide Receptor 2 Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 233. North America N-Formyl Peptide Receptor 2 Market Size, by Sepsis And Infectious Disease, 2017-2032 (USD Million)
TABLE 234. North America N-Formyl Peptide Receptor 2 Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 235. North America N-Formyl Peptide Receptor 2 Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 236. North America N-Formyl Peptide Receptor 2 Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 237. North America N-Formyl Peptide Receptor 2 Market Size, by Small Molecules, 2017-2032 (USD Million)
TABLE 238. North America N-Formyl Peptide Receptor 2 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. North America N-Formyl Peptide Receptor 2 Market Size, by Agonists, 2017-2032 (USD Million)
TABLE 240. North America N-Formyl Peptide Receptor 2 Market Size, by Allosteric Modulators, 2017-2032 (USD Million)
TABLE 241. North America N-Formyl Peptide Receptor 2 Market Size, by Antagonists, 2017-2032 (USD Million)
TABLE 242. North America N-Formyl Peptide Receptor 2 Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 243. North America N-Formyl Peptide Receptor 2 Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 244. North America N-Formyl Peptide Receptor 2 Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 245. North America N-Formyl Peptide Receptor 2 Market Size, by Oral, 2017-2032 (USD Million)
TABLE 246. North America N-Formyl Peptide Receptor 2 Market Size, by Topical, 2017-2032 (USD Million)
TABLE 247. North America N-Formyl Peptide Receptor 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. North America N-Formyl Peptide Receptor 2 Market Size, by CROs And Research Institutions, 2017-2032 (USD Million)
TABLE 249. North America N-Formyl Peptide Receptor 2 Market Size, by Healthcare Providers And Labs, 2017-2032 (USD Million)
TABLE 250. North America N-Formyl Peptide Receptor 2 Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 251. Latin America N-Formyl Peptide Receptor 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 252. Latin America N-Formyl Peptide Receptor 2 Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 253. Latin America N-Formyl Peptide Receptor 2 Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 254. Latin America N-Formyl Peptide Receptor 2 Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 255. Latin America N-Formyl Peptide Receptor 2 Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 256. Latin America N-Formyl Peptide Receptor 2 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 257. Latin America N-Formyl Peptide Receptor 2 Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 258. Latin America N-Formyl Peptide Receptor 2 Market Size, by Sepsis And Infectious Disease, 2017-2032 (USD Million)
TABLE 259. Latin America N-Formyl Peptide Receptor 2 Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 260. Latin America N-Formyl Peptide Receptor 2 Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 261. Latin America N-Formyl Peptide Receptor 2 Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 262. Latin America N-Formyl Peptide Receptor 2 Market Size, by Small Molecules, 2017-2032 (USD Million)
TABLE 263. Latin America N-Formyl Peptide Receptor 2 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 264. Latin America N-Formyl Peptide Receptor 2 Market Size, by Agonists, 2017-2032 (USD Million)
TABLE 265. Latin America N-Formyl Peptide Receptor 2 Market Size, by Allosteric Modulators, 2017-2032 (USD Million)
TABLE 266. Latin America N-Formyl Peptide Receptor 2 Market Size, by Antagonists, 2017-2032 (USD Million)
TABLE 267. Latin America N-Formyl Peptide Receptor 2 Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 268. Latin America N-Formyl Peptide Receptor 2 Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 269. Latin America N-Formyl Peptide Receptor 2 Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 270. Latin America N-Formyl Peptide Receptor 2 Market Size, by Oral, 2017-2032 (USD Million)
TABLE 271. Latin America N-Formyl Peptide Receptor 2 Market Size, by Topical, 2017-2032 (USD Million)
TABLE 272. Latin America N-Formyl Peptide Receptor 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. Latin America N-Formyl Peptide Receptor 2 Market Size, by CROs And Research Institutions, 2017-2032 (USD Million)
TABLE 274. Latin America N-Formyl Peptide Receptor 2 Market Size, by Healthcare Providers And Labs, 2017-2032 (USD Million)
TABLE 275. Latin America N-Formyl Peptide Receptor 2 Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 276. Europe N-Formyl Peptide Receptor 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 277. Europe N-Formyl Peptide Receptor 2 Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 278. Europe N-Formyl Peptide Receptor 2 Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 279. Europe N-Formyl Peptide Receptor 2 Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 280. Europe N-Formyl Peptide Receptor 2 Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 281. Europe N-Formyl Peptide Receptor 2 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 282. Europe N-Formyl Peptide Receptor 2 Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 283. Europe N-Formyl Peptide Receptor 2 Market Size, by Sepsis And Infectious Disease, 2017-2032 (USD Million)
TABLE 284. Europe N-Formyl Peptide Receptor 2 Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 285. Europe N-Formyl Peptide Receptor 2 Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 286. Europe N-Formyl Peptide Receptor 2 Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 287. Europe N-Formyl Peptide Receptor 2 Market Size, by Small Molecules, 2017-2032 (USD Million)
TABLE 288. Europe N-Formyl Peptide Receptor 2 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 289. Europe N-Formyl Peptide Receptor 2 Market Size, by Agonists, 2017-2032 (USD Million)
TABLE 290. Europe N-Formyl Peptide Receptor 2 Market Size, by Allosteric Modulators, 2017-2032 (USD Million)
TABLE 291. Europe N-Formyl Peptide Receptor 2 Market Size, by Antagonists, 2017-2032 (USD Million)
TABLE 292. Europe N-Formyl Peptide Receptor 2 Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 293. Europe N-Formyl Peptide Receptor 2 Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 294. Europe N-Formyl Peptide Receptor 2 Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 295. Europe N-Formyl Peptide Receptor 2 Market Size, by Oral, 2017-2032 (USD Million)
TABLE 296. Europe N-Formyl Peptide Receptor 2 Market Size, by Topical, 2017-2032 (USD Million)
TABLE 297. Europe N-Formyl Peptide Receptor 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 298. Europe N-Formyl Peptide Receptor 2 Market Size, by CROs And Research Institutions, 2017-2032 (USD Million)
TABLE 299. Europe N-Formyl Peptide Receptor 2 Market Size, by Healthcare Providers And Labs, 2017-2032 (USD Million)
TABLE 300. Europe N-Formyl Peptide Receptor 2 Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 301. Middle East N-Formyl Peptide Receptor 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 302. Middle East N-Formyl Peptide Receptor 2 Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 303. Middle East N-Formyl Peptide Receptor 2 Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 304. Middle East N-Formyl Peptide Receptor 2 Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 305. Middle East N-Formyl Peptide Receptor 2 Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 306. Middle East N-Formyl Peptide Receptor 2 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 307. Middle East N-Formyl Peptide Receptor 2 Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 308. Middle East N-Formyl Peptide Receptor 2 Market Size, by Sepsis And Infectious Disease, 2017-2032 (USD Million)
TABLE 309. Middle East N-Formyl Peptide Receptor 2 Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 310. Middle East N-Formyl Peptide Receptor 2 Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 311. Middle East N-Formyl Peptide Receptor 2 Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 312. Middle East N-Formyl Peptide Receptor 2 Market Size, by Small Molecules, 2017-2032 (USD Million)
TABLE 313. Middle East N-Formyl Peptide Receptor 2 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 314. Middle East N-Formyl Peptide Receptor 2 Market Size, by Agonists, 2017-2032 (USD Million)
TABLE 315. Middle East N-Formyl Peptide Receptor 2 Market Size, by Allosteric Modulators, 2017-2032 (USD Million)
TABLE 316. Middle East N-Formyl Peptide Receptor 2 Market Size, by Antagonists, 2017-2032 (USD Million)
TABLE 317. Middle East N-Formyl Peptide Receptor 2 Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 318. Middle East N-Formyl Peptide Receptor 2 Market Size, by Inhalation, 2017-2032 (USD Million)
TABLE 319. Middle East N-Formyl Peptide Receptor 2 Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 320. Middle East N-Formyl Peptide Receptor 2 Market Size, by Oral, 2017-2032 (USD Million)
TABLE 321. Middle East N-Formyl Peptide Receptor 2 Market Size, by Topical, 2017-2032 (USD Million)
TABLE 322. Middle East N-Formyl Peptide Receptor 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. Middle East N-Formyl Peptide Receptor 2 Market Size, by CROs And Research Institutions, 2017-2032 (USD Million)
TABLE 324. Middle East N-Formyl Peptide Receptor 2 Market Size, by Healthcare Providers And Labs, 2017-2032 (USD Million)
TABLE 325. Middle East N-Formyl Peptide Receptor 2 Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 326. Africa N-Formyl Peptide Receptor 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 327. Africa N-Formyl Peptide Receptor 2 Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 328. Africa N-Formyl Peptide Receptor 2 Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 329. Africa N-Formyl Peptide Receptor 2 Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 330. Africa N-Formyl Peptide Receptor 2 Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 331. Africa N-Formyl Peptide Receptor 2 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 332. Africa N-Formyl Peptide Receptor 2 Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 333. Africa N-Formyl Peptide Receptor 2 Market Size, by Sepsis And Infectious Disease, 2017-2032 (USD Million)
TABLE 334. Africa N-Formyl Peptide Receptor 2 Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 335. Africa N-Formyl Peptide Receptor 2 Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 336. Africa N-Formyl Peptide Receptor 2 Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 337. Africa N-Formyl Peptide Receptor 2 Market Size, by Small Molecules, 2017-2032 (USD Million)
TABLE 338. Africa N-Formyl Peptide Receptor 2 Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 339. Africa N-Formyl Peptide Receptor 2 Market Size, by Agonists, 2017-2032 (USD Million)
TABLE 340. Africa N-Formyl Peptide Receptor 2 Market Size, by Allosteric Modulators, 2017-2032 (USD Million)
TABLE 341. Africa N-Formyl Peptide Receptor 2 Market Size, by Antagonists, 2017-2032 (USD Million)
TABLE 342. Africa N-Formyl Peptide Receptor 2 Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 343. Africa N-Formyl Peptide Receptor 2 Market Size, by Inhalati

Companies Mentioned

  • Abcam plc
  • Alomone Labs Ltd
  • Amgen Inc
  • AstraZeneca plc
  • Bachem Holding AG
  • Bio-Techne Corporation
  • BioGems International Inc
  • Bristol-Myers Squibb Company
  • DiscoverX Corporation
  • Eli Lilly and Company
  • Enzo Life Sciences Inc
  • GenScript Biotech Corporation
  • Grünenthal GmbH
  • Ipsen Pharma SAS
  • Kyorin Pharmaceutical Co Ltd
  • MedChemExpress LLC
  • Merck KGaA
  • Novacell Technology Inc
  • Novartis AG
  • Novonesis A/S
  • PolyPeptide Group AG
  • Sanofi S.A.
  • Thermo Fisher Scientific Inc

Related Topics

Related Reports

N-Formyl Peptide Receptor 2 Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

N-Formyl Peptide Receptor 2 Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 73 Pages
  • Global
From
Formyl Peptide Receptor - Pipeline Insight, 2025 - Product Image

Formyl Peptide Receptor - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Integrin Inhibitors Market - Global Forecast 2026-2032 - Product Image

Integrin Inhibitors Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
C-X-C Chemokine Receptor Type 2 Market Report 2026 - Product Image

C-X-C Chemokine Receptor Type 2 Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Interleukin 8 Receptor Antagonists - Pipeline Insight, 2025 - Product Image

Interleukin 8 Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.